Clinical trials for medicines: Inclusion and Diversity Plan pilot findings published
What was announced
The Health Research Authority (HRA) has published the findings from its pilot on researchers and sponsors of clinical trials and clinical investigations developing and submitting an Inclusion and Diversity Plan.
Key points, in the publisher's words
- During the pilot, which ran for 6 months in 2025, the Medicines and Healthcare products Regulatory Agency’s (MHRA) and the HRA’s draft guidance on developing a plan was tested by a small group of commercial and non-commercial researchers and sponsors.
- The group submitted a Plan alongside their application for a Research Ethics Committee (REC) review.
- The Plan helps researchers consider and demonstrate how they plan to enrol the full range of people who will use the drugs, devices or intervention they are testing.
Who and where
UK bodies of power
- Medicines and Healthcare products Regulatory Agency (executive agency) · more news
- Health Research Authority (executive non-departmental public body) · more news
Where this sits in the 10 levels of power
Topics, as GOV.UK files them: Clinical trials and investigations.
Receipt
- Original: https://www.gov.uk/government/news/clinical-trials-for-medicines-inclusion-and-diversity-plan-pilot-findings-published
- Published 2026-11-03 09:30:19 UTC
- Read by this site 2026-11-03 10:00:08 UTC from GOV.UK
- Saved copy: receipt 7230, with its SHA-256 fingerprint
Contains public sector information licensed under the Open Government Licence v3.0.
Related official news
- MHRA launches patient safety essay competition for MedSafetyWeek
- Triheptanoin (Dojolvi) approved to treat adults and children with a group of rare inherited disorders
- MHRA approves gene-editing treatment for children aged five and over with serious inherited blood disorders
- New MHRA research puts needle-free Strep A vaccine within reach
- MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults
- MHRA approves new oral treatment for moderate to severe plaque psoriasis
More from GOV.UK
- RSH launches independent inquiry into social housing landlord
- Giant 12-tonne box lowered into place for fusion upgrade
- New plans “resurrect” genuine pensions for millions of private sector workers
- Maritime Big Play showcases the strength of UKDI investment in AUKUS innovation
- Raj Jethwa reappointed as a member of the Prison Service Pay Review Body
- New Co-Chair for Nuclear Decommissioning Authority NGO Forum
Also announced on 3 November 2026
- Regulators explore credit union reforms to support growth, innovation and better outcomes for members
- Taking care of others despite fear: a doctor facing Ebola
- Underscoring Expanding Reach of Information, Fourth Committee Stresses Need for Accuracy, Multilingualism, Smarter Technology in UN Communications
- General Assembly Condemns Threats to International Criminal Court, as Tribunal’s Presidents Warns of Unprecedented Challenges to Its Independence